Pablo E Pergola

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Chronic Kidney Disease

Placebo Controlled

Top Venues

Journal of the American Society of Nephrology : JASN

This page only lists publications with an associated author ORCID identifier.

Publications

Hiddo J Lambers Heerspink, David Cherney, Abdul Halim Abdul Gafor, Jose Luis Gorriz Teruel, Pablo E Pergola, Sydney Chi-Wai Tang, Marc Desch, Hristo Iliev, Zhichao Sun, Dominik Steubl, Masaomi Nangaku
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials. Journal of the American Society of Nephrology : JASN (2024)
Hiddo J Lambers Heerspink, David Cherney, Abdul Halim Abdul Gafor, Jose Luis Gorriz Teruel, Pablo E Pergola, Sydney Chi-Wai Tang, Marc Desch, Hristo Iliev, Zhichao Sun, Dominik Steubl, Masaomi Nangaku
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials. Journal of the American Society of Nephrology : JASN (2024)
Hiddo J Lambers Heerspink, David Cherney, Abdul Halim Abdul Gafor, Jose Luis Gorriz Teruel, Pablo E Pergola, Sydney Chi-Wai Tang, Marc Desch, Hristo Iliev, Zhichao Sun, Dominik Steubl, Masaomi Nangaku
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials. Journal of the American Society of Nephrology : JASN (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Hiddo J Lambers Heerspink, David Cherney, Abdul Halim Abdul Gafor, Jose Luis Gorriz Teruel, Pablo E Pergola, Sydney Chi-Wai Tang, Marc Desch, Hristo Iliev, Zhichao Sun, Dominik Steubl, Masaomi Nangaku
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials. Journal of the American Society of Nephrology : JASN (2024)
Hiddo J Lambers Heerspink, David Cherney, Abdul Halim Abdul Gafor, Jose Luis Gorriz Teruel, Pablo E Pergola, Sydney Chi-Wai Tang, Marc Desch, Hristo Iliev, Zhichao Sun, Dominik Steubl, Masaomi Nangaku
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials. Journal of the American Society of Nephrology : JASN (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Hiddo J Lambers Heerspink, Vlado Perkovic, Katherine R Tuttle, Pablo E Pergola, Kenneth W Mahaffey, Uptal D Patel, Julie H Ishida, Albert Kuo, Fang Chen, Robert Kustra, Vladimir Petrovic, Ellen Burgess, Naoki Kashihara, Glenn M Chertow
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial. Journal of the American Society of Nephrology : JASN (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine R Tuttle, Vlado Perkovic
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE). Journal of the American Society of Nephrology : JASN (2023)